Pickar D - Search Results

1

Clinical investigation of monoamine neurotransmitter interactions.

Hsiao JK, Potter WZ, Agren H, Owen RR, Pickar D. Hsiao JK, et al. Among authors: pickar d. Psychopharmacology (Berl). 1993;112(1 Suppl):S76-84. doi: 10.1007/BF02245010. Psychopharmacology (Berl). 1993. PMID: 7831444 Review.

2

Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.

Hsiao JK, Colison J, Bartko JJ, Doran AR, Konicki PE, Potter WZ, Pickar D. Hsiao JK, et al. Among authors: pickar d. Arch Gen Psychiatry. 1993 Aug;50(8):606-14. doi: 10.1001/archpsyc.1993.01820200016002. Arch Gen Psychiatry. 1993. PMID: 7688209

3

Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia.

Pickar D, Breier A, Hsiao JK, Doran AR, Wolkowitz OM, Pato CN, Konicki PE, Potter WZ. Pickar D, et al. Arch Gen Psychiatry. 1990 Jul;47(7):641-8. doi: 10.1001/archpsyc.1990.01810190041006. Arch Gen Psychiatry. 1990. PMID: 1694425

4

Predictors of clozapine response in schizophrenia.

Pickar D, Owen RR Jr, Litman RE, Hsiao JK, Su TP. Pickar D, et al. J Clin Psychiatry. 1994 Sep;55 Suppl B:129-32. J Clin Psychiatry. 1994. PMID: 7525541 Clinical Trial.

5

Idazoxan, an alpha 2 antagonist, augments fluphenazine in schizophrenic patients: a pilot study.

Litman RE, Hong WW, Weissman EM, Su TP, Potter WZ, Pickar D. Litman RE, et al. Among authors: pickar d. J Clin Psychopharmacol. 1993 Aug;13(4):264-7. J Clin Psychopharmacol. 1993. PMID: 8104200 Clinical Trial.

6

Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia.

Owen RR Jr, Gutierrez-Esteinou R, Hsiao J, Hadd K, Benkelfat C, Lawlor BA, Murphy DL, Pickar D. Owen RR Jr, et al. Among authors: pickar d. Arch Gen Psychiatry. 1993 Aug;50(8):636-44. doi: 10.1001/archpsyc.1993.01820200046005. Arch Gen Psychiatry. 1993. PMID: 8343034 Clinical Trial.

7

Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine.

Litman RE, Su TP, Potter WZ, Hong WW, Pickar D. Litman RE, et al. Among authors: pickar d. Br J Psychiatry. 1996 May;168(5):571-9. doi: 10.1192/bjp.168.5.571. Br J Psychiatry. 1996. PMID: 8733795 Clinical Trial.

8

Cerebrospinal fluid monoamine metabolites in childhood-onset schizophrenia.

Jacobsen LK, Frazier JA, Malhotra AK, Karoum F, McKenna K, Gordon CT, Hamburger SD, Lenane MC, Pickar D, Potter WZ, Rapoport JL. Jacobsen LK, et al. Among authors: pickar d. Am J Psychiatry. 1997 Jan;154(1):69-74. doi: 10.1176/ajp.154.1.69. Am J Psychiatry. 1997. PMID: 8988961

9

The acute effects of central- and peripheral-acting dopamine antagonists on plasma HVA in schizophrenic patients.

Konicki PE, Owen RR, Litman RE, Pickar D. Konicki PE, et al. Among authors: pickar d. Life Sci. 1991;48(14):1411-6. doi: 10.1016/0024-3205(91)90438-h. Life Sci. 1991. PMID: 2008157

10

Plasma norepinephrine in chronic schizophrenia.

Breier A, Wolkowitz OM, Roy A, Potter WZ, Pickar D. Breier A, et al. Among authors: pickar d. Am J Psychiatry. 1990 Nov;147(11):1467-70. doi: 10.1176/ajp.147.11.1467. Am J Psychiatry. 1990. PMID: 2221157

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters